NERVGEN PHARMA CORP. Basic Earnings Loss Per Share
NERVGEN PHARMA CORP. (NGEN) reported Basic Earnings Loss Per Share of -0.61 CAD/shares for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:BasicEarningsLossPerShare · last filed 2026-03-31
| Period end | Basic Earnings Loss Per Share 12 month |
|---|---|
| 2025-12-31 | -0.61 CAD/shares 40-F · filed 2026-03-31 |
| 2024-12-31 | -0.36 CAD/shares 40-F · filed 2026-03-31 |